A study which aims to evaluate the use of the drug ketamine as a treatment for people with severe alcohol disorder, or alcoholism, is currently recruiting volunteers in the South West.
‘KARE’ (Ketamine for reduction of Alcoholic Relapse) was awarded funding through the Biomedical Catalyst, a joint initiative between the Medical Research Council (MRC) and Innovate UK to support...
